Skip to content
AnalystLens

AXON ENTERPRISE, INC. 8-K/A Report, Unregistered Securities Sale (Mar 14, 2025)

Reports
Securities & Listing·Other Events·Exhibits & Filings
Filing Date
Filed March 14, 2025
Period End
March 6, 2025
Security
AXON
In the record · 2016–202610-K1210-Q328-K122

AXON filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Aug ’18Aug ’18
  2. Material agreement8-K · Sep ’20Sep ’20
  3. Leadership change8-K · Dec ’22Dec ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K/A filed March 14, 2025. Cited figures are marked; the original filing is the authoritative source.

Axon Enterprise, Inc. (AXON) has filed an 8-K report detailing the conclusion of privately negotiated exchange transactions involving its 0.50%a Convertible Senior Notes due 2027.

The company successfully exchanged approximately $407.5 millionb in aggregate principal amount of these notes for a combination of cash and newly issued shares of Axon's common stock. This transaction aims to reduce outstanding convertible debt and modify the company's capital structure.

Key Highlights

  1. Axon completed privately negotiated exchange transactions for its 0.50% Convertible Senior Notes due 2027.
  2. Approximately $407.5 million of convertible notes were exchanged.
  3. The company paid $407.95 million in cash (including accrued interest and fractional shares) to noteholders.
  4. Axon issued approximately 1.04 million shares of its common stock as part of the exchange.
  5. The transaction effectively reduces Axon's outstanding convertible debt.
  6. This filing also incorporates information related to unregistered sales of equity securities.

Frequently Asked Questions

  1. What was the primary purpose of these exchange transactions?

    The primary purpose was to reduce Axon's outstanding convertible senior debt and simplify its capital structure by exchanging these notes for a combination of cash and newly issued common stock.

  2. How much of Axon's convertible debt was affected?

    Approximately $407,453,000 in aggregate principal amount of the 0.50% Convertible Senior Notes due 2027 were exchanged.

  3. What did the noteholders receive in exchange for their notes?

    Noteholders received an aggregate principal amount of $407,954,826.34 in cash, which included accrued interest and fractional shares, as well as an aggregate of 1,038,259 shares of Axon's common stock.

  4. Does this transaction dilute existing shareholders?

    Yes, the issuance of approximately 1.04 million shares of common stock represents a dilutive event for existing shareholders. Investors should assess the impact of this new equity on earnings per share and ownership percentages.